Fixed-Dose PCC Dosing for Vitamin K Antagonist-Associated Hemorrhage: Is it Safe and Effective?
What is the literature behind fixed-dose PCC for reversal of vitamin K antagonist-associated bleeding? Can you use this for your next shift?
What is the literature behind fixed-dose PCC for reversal of vitamin K antagonist-associated bleeding? Can you use this for your next shift?
“Balance between bleeding and thrombosis”
Novel medications like dabigatran and rivaroxaban are increasingly being used to treat patients requiring anticoagulation, but management of bleeding can be a real challenge. Jake Rabe, MD discusses recent trials and reversal strategies.
Novel Anticoagulants and Bleeding in the Emergency Department Read More »